Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BI-1910 |
Synonyms | |
Therapy Description |
BI-1910 is an agonistic antibody that targets TNFR2, potentially leading to activation of an anti-tumor immune response (J Immunother Cancer 2023;11). |